Proficio Capital Partners LLC Dexcom Inc Transaction History

Proficio Capital Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$104.0 - $122.92 $12.3 Million - $14.6 Million	118,736 New	118,736 $13.8 Million
Q4 2021 Feb 11, 2022	SELL	$129.87 - $162.82 $55,064 - $69,035	-424 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $45,245 - $60,708	424 New	424 $232,000
Q3 2019 Nov 13, 2019	SELL	$35.53 - $43.8 $6,004 - $7,402	-169 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$27.84 - $38.92 $501 - $700	18 Added 11.92%	169 $25,000
Q1 2019 May 13, 2019	BUY	$28.07 - $38.18 $252 - $343	9 Added 6.34%	151 $18,000
Q4 2018 Feb 08, 2019	BUY	$26.99 - $37.37 $215 - $298	8 Added 5.97%	142 $17,000
Q4 2017 Feb 09, 2018	BUY	$11.12 - $15.38 $133 - $184	12 Added 9.84%	134 $8,000
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $1,385 - $2,315	122	122 $6,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.